Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04827576
Title Study of Magrolimab in Participants With Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Gilead Sciences
Indications

Advanced Solid Tumor

transitional cell carcinoma

lung small cell carcinoma

lung non-small cell carcinoma

Therapies

Docetaxel + Hu5F9-G4

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST